Description of the Immune Response to Yellow Fever Vaccination

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Vaccine protection depends on a specific adaptive immune memory. However, a little-explored aspect of certain live vaccines may provide beneficial, non-specific protection against infections or pathogens other than the one from which the vaccine is derived. This is the concept of innate immune memory or trained immunity, which differs from adaptive memory in its non-specificity. Innate immune memory is triggered by exposure to immunostimulants, and offers protection against unrelated pathogenic threats for several months or even years. The project aims to carry out an exploratory study to observe, in the context of current practice, the immune response obtained after a subunit and a live attenuated vaccine

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Age between 18 and 65

• Referred for immunisation against yellow fever and typhoid

• Any person with indication for the following vaccinations :

• Yellow fever

• Typhoïd

• Whose vaccination schedule includes two appointments 7 days apart

• Whose state of health is compatible with a single 51 ml blood sample collection

• Have consented to participate in the Ivory2 study

• Benefiting from a Social Security plan or equivalent

Locations
Other Locations
France
Centre Médical de l'Institut Pasteur
RECRUITING
Paris
Contact Information
Primary
Jessica Quintin, Dr
jessica.quintin@pasteur.fr
144389454
Backup
Sandrine Fernandes Pellerin
sandrine.fernandes-pellerin@pasteur.fr
145688179
Time Frame
Start Date: 2024-09-30
Estimated Completion Date: 2027-04-30
Participants
Target number of participants: 38
Treatments
Other: People with an indication for primary immunization against yellow fever and typhoid
People with an indication for primary immunization against yellow fever and typhoid and whose vaccination schedule includes two appointments 7 days apart
Related Therapeutic Areas
Sponsors
Leads: Institut Pasteur

This content was sourced from clinicaltrials.gov